Your new post is loading...
Via Jacob Blumenthal
|
Rescooped by Abdul Majeed Alwan from Stem Cells & Tissue Engineering |
Scoop.it!
Via Jacob Blumenthal
Abdul Majeed Alwan's insight:
it is important to use stem cells from different safe origins to treat a non treatable cases
Review summary: "Stem cell therapy for retinal disease is under way, and several clinical trials are currently recruiting. These trials use human embryonic, foetal and umbilical cord tissue-derived stem cells and bone marrow-derived stem cells to treat visual disorders such as age-related macular degeneration, Stargardt's disease and retinitis pigmentosa. Over a decade of analysing the developmental cues involved in retinal generation and stem cell biology, coupled with extensive surgical research, have yielded differing cellular approaches to tackle these retinopathies. Here, we review these various stem cell-based approaches for treating retinal diseases and discuss future directions and challenges for the field".